Retina Vasculomics® Platform for Diabetic Retinopathy

About Optotree

OptoTree is a private, pre-revenue diagnostics company leveraging its proprietary Vasculomics® platform to analyze 3D micro-vascular geometry from OCT-A scans for the early detection and staging of diabetic retinopathy. Formed as a collaboration between Joslin Diabetes Center and Vasculomics Holdings Group, the company aims to commercialize a cloud-based diagnostic service for clinics and eventually provide data informatics. Its technology, originally used in oncology drug discovery, is being repurposed to address a critical need in diabetic eye care, with a significant market opportunity driven by the global diabetes epidemic.

Therapeutic Areas